FdaApplication
ANDA 220239
Identifiers
- fda_app_no: ANDA220239
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2026-03-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBUPROFEN | IBUPROFEN | 100MG/5ML | SUSPENSION;ORAL |
1 product